Get the app
Allison DeAngelis
National biotech reporter and regular host of The Readout LOUD, moderating conversations and interviewing industry leaders on biotech business and policy.
Best podcasts with Allison DeAngelis
Ranked by the Snipd community
Oct 30, 2024
• 1h 1min
Episode 118
chevron_right
In this enlightening discussion, Allison DeAngelis, a prominent biotech commentator, and Matt Glein, CEO of Roivant, delve into the current surge in funding for neuropsychiatric diseases, spotlighting Seaport Therapeutics’ impressive $225 million Series B round. They weigh the merits of diversified versus focused pipelines and examine the hub-and-spoke model's implications. The conversation touches on the promising Phase 2 results from Alto Neurosciences and Vertex's innovative pain management approach, ultimately painting a vibrant picture of the biotech landscape.
The AI-powered Podcast Player
Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
Get the app
